Wendy Chang
Human Resources Officer bij HARPOON THERAPEUTICS, INC.
Profiel
Wendy Chang is currently the Chief People Officer at Harpoon Therapeutics, Inc. She previously worked at IDbyDNA, Inc. as the Head of People & Culture.
Ms. Chang completed her undergraduate degree at the University of California.
Actieve functies van Wendy Chang
| Bedrijven | Functie | Begin |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Human Resources Officer | 06-07-2022 |
Eerdere bekende functies van Wendy Chang
| Bedrijven | Functie | Einde |
|---|---|---|
IDbyDNA, Inc.
 IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Human Resources Officer | - |
Opleiding van Wendy Chang
| University of California | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HARPOON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Health Technology |